HCID 21962742, compound → HCID 21962744, compound

HRID 2212247Notes

Reaction equation

[F:1][C:2]([F:14])([F:13])[CH2:3][NH:4][C:5]([N:7]1[CH2:12][CH2:11][O:10][CH2:9][CH2:8]1)=S.Cl.[O:16]1[C:20]2[CH:21]=[CH:22][CH:23]=[CH:24][C:19]=2[N:18]=[C:17]1[CH:25]([OH:38])[CH:26]([NH:29][C:30](=[O:37])[CH:31]([NH2:36])[CH2:32][CH:33]([CH3:35])[CH3:34])[CH2:27][CH3:28].O1[C:43]2C=CC=[CH:47][C:42]=2N=C1C(C(NC(=O)C(NC1C2C=CC=CC=2S(=O)(=O)N=1)CC(C)C)CC)=O>>[O:16]1[C:20]2[CH:21]=[CH:22][CH:23]=[CH:24][C:19]=2[N:18]=[C:17]1[CH:25]([OH:38])[CH:26]([NH:29][C:30](=[O:37])[CH:31]([NH:36][C:5]([N:7]1[CH2:12][CH2:11][O:10][CH2:9][CH2:8]1)=[N:4][CH2:3][C:2]([F:14])([F:13])[F:1])[CH2:32][CH:33]1[CH2:34][CH2:47][CH2:42][CH2:43][CH2:35]1)[CH2:27][CH3:28]

Participants

Reactant 3

HCID 21962742HCID 21962742, compound

HCID 47002562HCID 47002562, compound

HCID 178457766HCID 178457766, compound

Product 1

HCID 21962744HCID 21962744, compound

Procedure

Proceeding as described in Example 5 above, but substituting (morpholin-4-yl-carbothioyl)carbamic acid ethyl ester with morpholine-4-carbothioic acid (2,2,2-trifluoroethyl)amide and 2-amino-4-methylpentanoic acid [1-(benzoxazol-2-ylhydroxymethyl)propyl]amide hydrochloride with 2-amino-3-cyclohexylpropionic acid [1-(benzoxazol-2-ylhydroxymethyl)propyl]amide hydrochloride (prepared by reacting L-cyclohexyalanine with 2RS-amino-1-benzoxazol-2-yl-1-butanol as described in Example 1, step 2 above) provided N-[1-(benzoxazol-2-yl-hydroxy-methyl)-propyl]-3-cyclohexyl-2-{[N-(2,2,2-trifluoroethyl)-morpholine-4-carboximidoyl]-amino}-propionamide, Mol. Wt.: 553.62. MS: 552.5 (M−1), 554.7 (M+1).

Sources & evidence

ORD record: ord-40e24dd819474bf19f80a82bf3178737
Source dataset: uspto-grants-2006_09
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US07101880B2

Reaction notes

Loading…